PTRH2

peptidyl-tRNA hydrolase 2, the group of Cilia and flagella associated

Basic information

Region (hg38): 17:59674636-59707626

Links

ENSG00000141378NCBI:51651OMIM:608625HGNC:24265Uniprot:Q9Y3E5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1 (Definitive), mode of inheritance: AR
  • infantile multisystem neurologic-endocrine-pancreatic disease (Supportive), mode of inheritance: AR
  • neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1ARGastrointestinalThe condition has been described as including exocrine pancreatic insufficiency, among other manifestatons, and awareness may allow medical managementAudiologic/Otolaryngologic; Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic25558065; 25574476; 27129381; 28328138; 33092935

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PTRH2 gene.

  • Inborn_genetic_diseases (16 variants)
  • not_provided (14 variants)
  • Neurologic,_endocrine,_and_pancreatic_disease,_multisystem,_infantile-onset_1 (7 variants)
  • not_specified (4 variants)
  • PTRH2-related_disorder (3 variants)
  • Neurologic,_endocrine,_and_pancreatic_disease,_multisystem,_infantile-onset (2 variants)
  • Cerebellar_ataxia (1 variants)
  • Global_developmental_delay (1 variants)
  • Hearing_impairment (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTRH2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016077.5. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
6
clinvar
6
missense
1
clinvar
1
clinvar
17
clinvar
2
clinvar
21
nonsense
3
clinvar
3
start loss
0
frameshift
1
clinvar
2
clinvar
2
clinvar
5
splice donor/acceptor (+/-2bp)
0
Total 2 6 19 8 0

Highest pathogenic variant AF is 0.00000247822

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PTRH2protein_codingprotein_codingENST00000470557 132991
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0006380.51100000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4278394.70.8760.000004741158
Missense in Polyphen2233.5010.6567404
Synonymous-0.6844034.91.150.00000175368
Loss of Function0.28055.720.8743.79e-769

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: The natural substrate for this enzyme may be peptidyl- tRNAs which drop off the ribosome during protein synthesis. {ECO:0000250}.;
Disease
DISEASE: Neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset (IMNEPD) [MIM:616263]: A progressive multisystem disease characterized by a variety of neurologic, endocrine, and, in some patients, pancreatic features. Variable clinical symptoms include global developmental delay, hypotonia, hearing loss, ataxia, hyporeflexia, facial dysmorphism, hypothyroidism, and pancreatic insufficiency. {ECO:0000269|PubMed:25558065, ECO:0000269|PubMed:25574476}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Apoptosis Modulation and Signaling;Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;Deubiquitination (Consensus)

Recessive Scores

pRec
0.0903

Intolerance Scores

loftool
0.264
rvis_EVS
0.1
rvis_percentile_EVS
61.28

Haploinsufficiency Scores

pHI
0.442
hipred
N
hipred_score
0.354
ghis
0.514

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.987

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ptrh2
Phenotype
immune system phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype;

Gene ontology

Biological process
apoptotic process;negative regulation of gene expression;positive regulation of anoikis;negative regulation of anoikis
Cellular component
mitochondrion;cytosol;membrane
Molecular function
aminoacyl-tRNA hydrolase activity;protein binding